Skip to main content
Figure 2 | BMC Immunology

Figure 2

From: High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort

Figure 2

Gating strategy for NK cells. A- Total lymphocyte population, B- CD3 negative CD8 variable NK cells gated from the total lymphocyte population, C- CD14-/19- cells, D- total NK cell population gated off the CD14-/19- cells, E- different NK cell subsets; CD56bri (cytokine-producing NK cells)-CD56++ CD16-, CD56 dim (cytotoxic NK cells) -CD56+CD16+/-, CD56 neg (cytotoxic NK cells)-CD56-CD16+, F- CD16 PerCP-cy5.5 FMO, G- CD56 PE-Cy7 FMO and H- CD14/19-FITC FMO.

Back to article page